Eur Rev Med Pharmacol Sci 2023; 27 (1): 307-314

DOI: 10.26355/eurrev_202301_30877

Appropriateness of aspirin use among diabetic patients in primary prevention of atherosclerotic cardiovascular diseases: an analysis of the ASSOS study

E. Demirci, O. Celik, C. Cil, V.O. Tanık, K. Memic Sancar, O. Orscelik, M.M. Resulzade, C. Kaya, T. Kırıs, V. Dogan, O. Basaran

Department of Cardiology, Kayseri City Hospital, Kayseri, Turkey. demirci.e@hotmail.com


OBJECTIVE: Aspirin is an essential drug in the prevention of atherosclerotic cardiovascular disease (ASCVD). It is ultimately indicated in a patient with ASCVD. However, its role is debated in primary prevention. We aimed to investigate the appropriateness of aspirin use in diabetic patients according to recommendations of recent guidelines.

PATIENTS AND METHODS: ASSOS was a multicenter observational study investigating aspirin use in cardiology outpatient clinics. We evaluated aspirin use in diabetic patients in primary prevention from the ASSOS study. We also assessed the appropriate use of aspirin according to the European Society of Cardiology (ESC), American College of Cardiology/American Heart Association (ACC/AHA), American Diabetes Association (ADA), Consensus Statement of Endocrinology, Cardiology, and Nephrology (ENCARNE), and the United States Preventive Services Task Force (USPTF).

RESULTS: A total of 5,007 patients of whom 1,537 had type 2 diabetes mellitus (DM) were included in the study. 1,132 of the total participants used aspirin for primary prevention; 313 of them had type 2 DM. Only 248 (76.7%), 132 (40.8%), and 128 (39.6%) diabetic patients indicated aspirin use according to the ESC/INCARNE, ACC/AHA, and ADA/USPTF guidelines, respectively.

CONCLUSIONS: Inappropriate aspirin use was common among diabetic patients, according to clinical practice guideline recommendations. In addition, the differences between the indications for the use of aspirin in diabetic patients according to the guidelines were remarkable. Guidelines that minimize these differences are needed for clinicians, and compliance with these guidelines in clinical practice could reduce inappropriate aspirin use.

Free PDF Download

To cite this article

E. Demirci, O. Celik, C. Cil, V.O. Tanık, K. Memic Sancar, O. Orscelik, M.M. Resulzade, C. Kaya, T. Kırıs, V. Dogan, O. Basaran
Appropriateness of aspirin use among diabetic patients in primary prevention of atherosclerotic cardiovascular diseases: an analysis of the ASSOS study

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 1
Pages: 307-314
DOI: 10.26355/eurrev_202301_30877